Cargando…
Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly
BACKGROUND: Transsphenoidal adenomectomy (TSS) of somatotroph pituitary neuroendocrine tumor (PitNET) is the first-line treatment of acromegaly. Pharmacological treatment is recommended if surgery is contraindicated or did not lead to disease remission. The choice of treatment best fitting each pati...
Autores principales: | Tomasik, Agnieszka, Stelmachowska-Banaś, Maria, Maksymowicz, Maria, Czajka-Oraniec, Izabella, Raczkiewicz, Dorota, Zieliński, Grzegorz, Kunicki, Jacek, Zgliczyński, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523725/ https://www.ncbi.nlm.nih.gov/pubmed/36187106 http://dx.doi.org/10.3389/fendo.2022.957301 |
Ejemplares similares
-
Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation
por: Stelmachowska-Banaś, Maria, et al.
Publicado: (2021) -
Real-World Experience With Pasireotide Lar in Acromegaly Resistant to First-Generation Somatostatin Analogs: A Single Center 1-Year Observation
por: Stelmachowska-Banas, Maria, et al.
Publicado: (2021) -
Effects of acromegaly treatment on left ventricular systolic function assessed by speckle tracking echocardiography in relation to sex differences: results from a prospective single center study
por: Popielarz-Grygalewicz, Agata, et al.
Publicado: (2023) -
Skeletal complications in acromegaly
por: Wydra, Arnika, et al.
Publicado: (2023) -
Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly
por: Rymuza, Julia, et al.
Publicado: (2022)